远程医疗公司Hims & Hers Health Inc.（股票代码：HIMS）今日盘中股价大涨5.06%，引起市场广泛关注。这一涨幅可能与俄亥俄州即将出台的新规定有关，该规定可能对公司的减肥药业务产生影响。
据报道，俄亥俄州正在采取措施加强对该州大型配制药房的监管，包括那些生产减肥药复方制剂的药房。新规定将限制药房一次只能生产250单位的药品，这可能会影响Hims & Hers在俄亥俄州的业务运营。Hims & Hers自2020年起在俄亥俄州拥有一家药店，该公司2024年的收入中有19%来自减肥药物。
尽管新规定可能带来挑战，但Hims & Hers表示将继续与监管机构密切合作，遵守严格的安全标准。市场似乎对公司应对新规定的能力持积极态度，推动了股价上涨。然而，投资者仍需密切关注该规定的最终实施及其对公司业务的长期影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.